Current status and advances of radiotherapy for limited-disease small cell lung cancer
10.3760/cma.j.issn.1673-422X.2014.10.012
- VernacularTitle:局限期小细胞肺癌放疗现状及研究进展
- Author:
Dan HAN
;
Baosheng LI
- Publication Type:Journal Article
- Keywords:
Carcinoma,small cell;
Radiotherapy;
Limited disease
- From:
Journal of International Oncology
2014;41(10):757-760
- CountryChina
- Language:Chinese
-
Abstract:
About 30％ ～ 40％ of small cell lung cancer (SCLC) patients belong to limited disease (LD).In the setting of limited-disease small cell lung cancer (LD-SCLC),the combination of thoracic radiotherapy (TRT) with chemotherapy is the standard treatment for LD-SCLC with improved survival and local control.It is proven that prophylactic cranial irradiation can improve the prognosis of patients with SCLC.Radiotherapy should join in the early chemotherapy and individualized formulate appropriate target volume.Radiation schemes of conventional fractionation or hyperfractionation way are recommended.
